ABBVIE TO BUY RIVAL PHARMACEUTICAL COMPANY ALLERGAN IN "TRANSFORMATIVE" DEAL VALUED AT $63 BILLION

NEW YORK (AP) — AbbVie to buy rival pharmaceutical company Allergan in "transformative" deal valued at $63 billion. Read more on NewsOK.com

NewsOK.com (Date:06/25/2019 13:10) Read full article >>

Related News about "AbbVie to buy rival pharmaceutical company Allergan in "transformative" deal valued at $63 billion" news from other sites: (news similarity rate is shown on left.)

30%
US company trials coronavirus vaccine candidate in Australia CANBERRA, Australia (AP) — A U.S. biotechnology company began injecting a coronavirus vaccine candidate into people in Australia on Tuesday with hopes of releasing a proven vaccine this year. Nov.. NewsOK.com >>
19%
Of rumored $100M Spotify deal, podcaster Joe Rogan said it 'feels gross…seems fake' Previously seen on YouTube, Rogan's no-holds-barred interviews became viral sensations, earning him more than 10 million subscribers on the site since 2013. The former "Fear Factor" host announced the.. NY Daily News >>
22%
Mets' Noah Syndergaard tries comparing MLB coronavirus deal to his NYC rent fight New York Mets star Noah Syndergaard on Twitter compared his feud with the landlord of his $27,000-a-month Manhattan penthouse with Major League Baseball paying players their prorated salaries durin.. FoxNews.com >>
25%
Duterte orders probe of company allegedly selling overpriced medical equipment MANILA, Philippines – President Rodrigo Duterte urged the National Bureau of Investigation (NBI) to probe a couple who owned a company that allegedly tried to corner the government into purchasing.. Rappler.com >>
30%
US company trials coronavirus vaccine in Australia CANBERRA, Australia (AP) — A U.S. biotechnology company announced on Tuesday the start of human trials in Australia of a vaccine for the coronarvirus with hopes of releasing a proven vaccine this ye.. NewsOK.com >>
Allergan: